Loading stock data...

Jenburkt Pharmaceuticals Limited

BSE: JENBURPH

BSE
1,003.45 7.15 (0.72%)

Prev Close

996.3

Open Price

1001.8

Volume

324

Today Low / High

990 / 1007.8

52 WK Low / High

936.7 / 1410

Range

953 - 1,054

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 1003.45, reflecting a change of 7.15 (0.71766%). The expected target range on the BSE is 953 - 1,054. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

20 Feb 1,033.55 -0.75%
19 Feb 1,052.60 -1.82%
18 Feb 1,069.00 -0.48%
17 Feb 1,061.60 -0.41%
16 Feb 1,051.65 0.34%
13 Feb 1,026.60 2.95%
12 Feb 1,035.00 0.71%
11 Feb 1,076.60 -1.90%
10 Feb 1,062.60 0.40%
09 Feb 1,068.20 -0.04%
06 Feb 1,073.75 -0.92%
05 Feb 1,086.80 -2.42%
04 Feb 1,056.30 0.06%
03 Feb 1,076.60 2.59%
02 Feb 1,056.60 -2.11%
01 Feb 1,073.40 -2.19%
30 Jan 1,067.15 0.59%
29 Jan 1,088.60 -1.97%
28 Jan 1,094.00 -1.72%

Jenburkt Pharmaceuticals Limited Graph

Jenburkt Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Jenburkt Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,003.45, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,003.45 1,013.48 912.14 - 1,114.83
1,023.52 818.82 - 1,228.22
1,033.55 723.49 - 1,343.62
Bearish Scenario 1,003.45 993.42 894.07 - 1,092.76
983.38 786.70 - 1,180.06
973.35 681.34 - 1,265.35

Overview of Jenburkt Pharmaceuticals Limited

ISIN

INE354A01013

Industry

Medical - Pharmaceuticals

Vol.Avg

1,026

Market Cap

4,536,872,400

Last Dividend

18

Official Website

Visit Website

IPO Date

2000-11-27

DCF Diff

-217.61

DCF

1,243

Financial Ratios Every Investor Needs

Stock Dividend of JENBURPH

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-07-11 July 11, 25 18 18 2025-07-11 2025-08-17
2024-07-23 July 23, 24 15.3 15.3 2024-07-23 2024-08-29
2023-07-19 July 19, 23 14.4 14.4 2023-07-19 2023-08-25
2022-07-21 July 21, 22 12 12 2022-07-22 2022-08-28
2021-08-30 August 30, 21 10.2 10.2 2021-08-31 2021-10-07

Stock Rating Details for JENBURPH

Metric Value Recommendation
Overall Rating C Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 151.69 Cr 29.66 Cr 122.04 Cr 0.8045 0.43 Cr 3.72 Cr 76.50 Cr 32.06 Cr 72.65 40.39 Cr 0.2114
2024-03-31 141.97 Cr 31.34 Cr 110.62 Cr 0.7792 1.23 Cr 4.65 Cr 31.35 Cr 25.98 Cr 58.86 37.79 Cr 0.1830
2023-03-31 136.14 Cr 33.81 Cr 102.34 Cr 0.7517 1.23 Cr 4.08 Cr 28.61 Cr 24.61 Cr 53.90 35.49 Cr 0.1807
2022-03-31 123.73 Cr 32.06 Cr 91.67 Cr 0.7409 1.08 Cr 3.17 Cr 25.37 Cr 22.30 Cr 48.58 32.20 Cr 0.1802
2021-03-31 108.87 Cr 30.44 Cr 78.43 Cr 0.7204 0.98 Cr 4.78 Cr 18.76 Cr 16.50 Cr 35.96 24.15 Cr 0.1516

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 7.36 Cr 196.19 Cr 24.41 Cr 171.7771 Cr 3.89 Cr -20.75 Cr 8.88 Cr 54.71 Cr 0.00 Cr 0.00 Cr 80.47 Cr 18.8193 Cr
2024-03-31 4.13 Cr 165.10 Cr 20.16 Cr 144.9402 Cr 0.00 Cr -4.13 Cr 8.56 Cr 36.55 Cr 0.00 Cr 0.00 Cr -52.12 Cr 16.3788 Cr
2023-03-31 3.66 Cr 141.81 Cr 19.42 Cr 122.3897 Cr 2.93 Cr -0.73 Cr 8.34 Cr 22.71 Cr 0.06 Cr 0.00 Cr 36.87 Cr 15.7619 Cr
2022-03-31 5.03 Cr 142.95 Cr 25.57 Cr 117.3825 Cr 6.75 Cr 1.72 Cr 9.89 Cr 22.41 Cr 0.86 Cr 0.00 Cr 43.50 Cr 21.2798 Cr
2021-03-31 2.49 Cr 121.18 Cr 22.72 Cr 98.4663 Cr 5.07 Cr 2.57 Cr 7.58 Cr 10.45 Cr 1.21 Cr 0.00 Cr 29.20 Cr 17.9919 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 27.9060 Cr -17.0447 Cr -7.6219 Cr 8.1924 Cr 3.2394 Cr 7.3648 Cr -19.7136 Cr 32.0606 Cr 1.9788 Cr -6.7805 Cr -0.3186 Cr
2024-03-31 8.1238 Cr -0.5804 Cr -7.0779 Cr 5.5697 Cr 0.4655 Cr 4.1254 Cr -2.5541 Cr 25.9773 Cr -0.5100 Cr -6.3182 Cr -0.2241 Cr
2023-03-31 17.0520 Cr 2.6179 Cr -21.0413 Cr 14.9475 Cr -1.3714 Cr 3.6599 Cr -2.1045 Cr 24.6070 Cr -0.5100 Cr -5.4997 Cr 1.5500 Cr
2022-03-31 9.2714 Cr -1.2024 Cr -5.5314 Cr 6.2171 Cr 2.5376 Cr 5.0313 Cr -3.0543 Cr 22.2972 Cr -0.5100 Cr -4.6804 Cr -2.3062 Cr
2021-03-31 19.4548 Cr -18.7810 Cr -0.7141 Cr 18.3097 Cr -0.0403 Cr 2.4937 Cr -1.1451 Cr 16.5024 Cr 0.2717 Cr 0.0000 Cr 3.3172 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 43.02 Cr 24.33 Cr 18.69 Cr 0.4344 6.60 Cr 5.93 Cr 13.44 9.24 Cr 0.1379
2025-09-30 45.56 Cr 23.03 Cr 22.52 Cr 0.4944 12.36 Cr 10.16 Cr 23.03 15.18 Cr 0.2231
2025-06-30 35.53 Cr 6.52 Cr 29.01 Cr 0.8165 8.23 Cr 7.79 Cr 17.66 11.01 Cr 0.2193
2025-03-31 41.05 Cr 7.90 Cr 33.14 Cr 0.8075 21.71 Cr 8.54 Cr 19.34 10.75 Cr 0.2080
2024-12-31 36.89 Cr 7.19 Cr 29.71 Cr 0.8052 8.04 Cr 6.51 Cr 14.75 10.40 Cr 0.1764

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 9.65 Cr 0.00 Cr 9.65 Cr 23.15 Cr 10.17 Cr 45.37 Cr 65.54 Cr 209.07 Cr 26.19 Cr
2025-06-30 0.00 Cr 0.00 Cr 23.14 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -171.78 Cr
2025-03-31 7.36 Cr 15.78 Cr 23.14 Cr 20.73 Cr 8.88 Cr 56.53 Cr 54.71 Cr 196.19 Cr 24.41 Cr
2024-12-31 0.00 Cr 0.00 Cr 77.69 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -157.76 Cr
2024-09-30 77.69 Cr 0.00 Cr 77.69 Cr 15.21 Cr 8.94 Cr 104.20 Cr 14.68 Cr 181.48 Cr 23.71 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 7.79 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 8.54 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 6.51 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 9.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 7.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹854.80 ₹102,578,890,079.00 ₹242,213.00

Key Executives

Compliance Officer & Company Secretary
Ashish Rasiklal Shah

Gender: male

Year Born:

Chairman & MD
Ashish Uttam Bhuta

Gender: male

Year Born: 1973

Head of Sales- Wellness Division
Barani Dharan Sivaprakasam

Gender: male

Year Born: 1978

Head/General Manager of QA/QC
Bhanudas Narayan Kadam

Gender: male

Year Born:

Chief Financial Officer & Whole Time Director
Dilip Harkisandas Bhuta

Gender: male

Year Born: 1952

Head/General Manager of Information Technology
Jayesh D. Tanna

Gender: male

Year Born: 1965

Sr. General Manager of Technical & Site Head at Plant-Sihor
Ravindra Dnyandeo Mankar

Gender: male

Year Born:

Head of R&D and Projects at Plant, Sihor
Uday Kalele

Gender: male

Year Born: 1956

Head of International Business
Vinay L. Bhatt

Gender: male

Year Born: 1968

General Manager of HR & Admin
Virendra Zope

Gender: male

Year Born:

FAQs about Jenburkt Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is Ashish Uttam Bhuta.

What is the current market price of the stock?

The current price is ₹1,028.00.

What is the 52-week price range?

The range is ₹936.7-1410.

What is the market capitalization of the company?

The market capitalization is ₹453.69 crores.

What is the dividend yield?

The dividend yield is 1.75%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 13.99.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Jenburkt Pharmaceuticals Limited (ISIN: INE354A01013) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹453.69 crores and an average daily volume of 1,026 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹18.